Target intelligence / Profile preview

Lymphatic smooth muscle contractile apparatus and associated ion channels

Molecular classification
Ion channel, Enzyme, Motor protein, Cytoskeletal protein
01

Overview

The lymphatic smooth muscle contractile apparatus and associated ion channels constitute the physiological machinery responsible for the active propulsion of lymph through the lymphatic system (Scallan et al., 2016, Physiological Reviews). This system relies on a coordinated cycle of contraction and relaxation in lymphatic muscle cells, driven by the interaction of actin and myosin and regulated by intracellular calcium oscillations (Muthuchamy & Zawieja, 2008, Genes & Development). Key ion channels, such as L-type voltage-gated calcium channels (Cav1.2) and calcium-activated chloride channels (ANO1), initiate the action potentials necessary for myogenic activity (To et al., 2020, British Journal of Pharmacology). Dysregulation of this apparatus is a hallmark of primary and secondary lymphedema, where impaired pumping leads to fluid accumulation and tissue fibrosis (Zawieja, 2009, Annals of the New York Academy of Sciences). Pharmacological targeting of these components, such as using calcium channel modulators or phosphodiesterase inhibitors, aims to restore effective lymphatic drainage (Telinius & Hjortdal, 2019, Lymphatic Research and Biology). However, the high degree of homology between lymphatic and vascular smooth muscle presents a significant challenge for achieving tissue-specific therapeutic effects.

Other names
Lymphatic myogenic machineryLymphatic pump apparatusLymphatic contractile unit
02

Mechanism of action

Modulation of intracellular calcium levels and the phosphorylation of myosin light chains to regulate the frequency and strength of lymphatic vessel contractions.

03

Biological functions

Muscle contractionFluid transportIon homeostasisSignal transduction
04

Disease associations

LymphedemaInflammationCancer metastasisCardiovascular disease
05

Safety considerations

Systemic hypotensionPeripheral edemaAltered immune cell transportOff-target effects on vascular smooth muscle
06

Interacting drugs

Nifedipine

5 more in the full profile.

07

Biomarkers

Lymphatic contraction frequencyLymphatic vessel diameterMyosin light chain phosphorylation (p-MLC) levels

Beyond the preview

Go deeper on Lymphatic smooth muscle contractile apparatus and associated ion channels.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lymphatic smooth muscle contractile apparatus and associated ion channels.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call